SignatureFD’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.2K | Buy |
67
+36
| +116% | +$503 | ﹤0.01% | 3229 |
|
|
2026
Q1 | $292 | Buy |
+31
| New | +$340 | ﹤0.01% | 3355 |
|
|
2025
Q4 | – | Sell |
-634
| Closed | -$9.09K | – | 3464 |
|
|
2025
Q3 | $9.09K | Buy |
634
+10
| +2% | +$137 | ﹤0.01% | 2445 |
|
|
2025
Q2 | $7.66K | Buy |
624
+548
| +721% | +$7.96K | ﹤0.01% | 2440 |
|
|
2025
Q1 | $1.67K | Hold |
76
| – | – | ﹤0.01% | 2925 |
|
|
2024
Q4 | $1.72K | Buy |
+76
| New | +$1.66K | ﹤0.01% | 2914 |
|
|
2024
Q3 | – | Sell |
-94
| Closed | -$2.74K | – | 3278 |
|
|
2024
Q2 | $2.74K | Buy |
94
+58
| +161% | +$1.72K | ﹤0.01% | 2677 |
|
|
2024
Q1 | $1.28K | Sell |
36
-546
| -94% | -$21.8K | ﹤0.01% | 2905 |
|
|
2023
Q4 | $25.3K | Buy |
582
+415
| +249% | +$16.3K | ﹤0.01% | 1805 |
|
|
2023
Q3 | $6.38K | Sell |
167
-178
| -52% | -$7.49K | ﹤0.01% | 2403 |
|
|
2023
Q2 | $14.2K | Sell |
345
-220
| -39% | -$10.6K | ﹤0.01% | 2066 |
|
|
2023
Q1 | $32.4K | Buy |
565
+144
| +34% | +$8.11K | ﹤0.01% | 1611 |
|
|
2022
Q4 | $23.6K | Buy |
421
+3
| +0.7% | +$153 | ﹤0.01% | 1719 |
|
|
2022
Q3 | $18K | Buy |
418
+247
| +144% | +$12.7K | ﹤0.01% | 1784 |
|
|
2022
Q2 | $9K | Buy |
171
+5
| +3% | +$300 | ﹤0.01% | 2164 |
|
|
2022
Q1 | $11K | Buy |
166
+45
| +37% | +$2.96K | ﹤0.01% | 2111 |
|
|
2021
Q4 | $8K | Sell |
121
-15
| -11% | -$1.01K | ﹤0.01% | 2216 |
|
|
2021
Q3 | $9K | Buy |
136
+8
| +6% | +$565 | ﹤0.01% | 2115 |
|
|
2021
Q2 | $9K | Buy |
128
+7
| +6% | +$495 | ﹤0.01% | 2034 |
|
|
2021
Q1 | $8K | Hold |
121
| – | – | ﹤0.01% | 1950 |
|
|
2020
Q4 | $8K | Sell |
121
-41
| -25% | -$2.21K | ﹤0.01% | 1786 |
|
|
2020
Q3 | $8K | Buy |
162
+58
| +56% | +$2.76K | ﹤0.01% | 1722 |
|
|
2020
Q2 | $5K | Sell |
104
-34
| -25% | -$1.67K | ﹤0.01% | 1804 |
|
|
2020
Q1 | $6K | Buy |
138
+94
| +214% | +$4.93K | ﹤0.01% | 1631 |
|
|
2019
Q4 | $3K | Hold |
44
| – | – | ﹤0.01% | 1788 |
|
|
2019
Q3 | $3K | Hold |
44
| – | – | ﹤0.01% | 1728 |
|
|
2019
Q2 | $2K | Buy |
44
+17
| +63% | +$875 | ﹤0.01% | 1763 |
|
|
2019
Q1 | $2K | Sell |
27
-51
| -65% | -$2.6K | ﹤0.01% | 1779 |
|
|
2018
Q4 | $4K | Buy |
78
+26
| +50% | +$1.43K | ﹤0.01% | 1576 |
|
|
2018
Q3 | $3K | Hold |
52
| – | – | ﹤0.01% | 1634 |
|
|
2018
Q2 | $3K | Hold |
52
| – | – | ﹤0.01% | 1652 |
|
|
2018
Q1 | $3K | Buy |
+52
| New | +$2.73K | ﹤0.01% | 1495 |
|
|
2016
Q2 | – | Sell |
-32
| Closed | -$1K | – | 1471 |
|
|
2016
Q1 | $1K | Hold |
32
| – | – | ﹤0.01% | 1275 |
|
|
2015
Q4 | $1K | Hold |
32
| – | – | ﹤0.01% | 1185 |
|
|
2015
Q3 | $1K | Sell |
32
-7
| -18% | -$219 | ﹤0.01% | 1131 |
|
|
2015
Q2 | $1K | Hold |
39
| – | – | ﹤0.01% | 967 |
|
|
2015
Q1 | $1K | Hold |
39
| – | – | ﹤0.01% | 882 |
|
|
2014
Q4 | $1K | Hold |
39
| – | – | ﹤0.01% | 799 |
|
|
2014
Q3 | $1K | Hold |
39
| – | – | ﹤0.01% | 640 |
|
|
2014
Q2 | $1K | Hold |
39
| – | – | ﹤0.01% | 786 |
|
|
2014
Q1 | $1K | Hold |
39
| – | – | ﹤0.01% | 693 |
|
|
2013
Q4 | $1K | Hold |
39
| – | – | ﹤0.01% | 647 |
|
|
2013
Q3 | $1K | Hold |
39
| – | – | ﹤0.01% | 593 |
|
|
2013
Q2 | $1K | Buy |
+39
| New | +$572 | ﹤0.01% | 511 |
|
Other funds holding IART
SIM
SFA
ETC
LSERS
SOADOR
PFSRSONJ
YCM
SignatureFD's IART Position: Q2 2026 in Review
SignatureFD increased its Integra LifeSciences (IART) stake by 116% in Q2 2026, buying an estimated $503 and bringing the position to 67 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3229.
SignatureFD first reported a position in IART in Q2 2013 and has held it in 44 quarters since. The position peaked at $32.4K in Q1 2023. 33 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- SignatureFD held 67 shares of Integra LifeSciences worth $1.2K as of Q2 2026.
- SignatureFD bought 36 Integra LifeSciences shares in Q2 2026, an estimated $503.
- Integra LifeSciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3229 holding.
- SignatureFD first reported a position in Integra LifeSciences in Q2 2013 and has held it in 44 quarters since.
- SignatureFD's Integra LifeSciences position peaked at $32.4K in Q1 2023.
- 33 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.